Literature DB >> 31376283

Radiomics for the prediction of EGFR mutation subtypes in non-small cell lung cancer.

Shu Li1, Changwei Ding2, Hao Zhang1, Jiangdian Song1, Lei Wu3.   

Abstract

PURPOSE: This retrospective study was designed to investigate the ability of radiomics to predict the mutation status of epidermal growth factor receptor (EGFR) subtypes (19Del and L858R) in patients with non-small cell lung cancer (NSCLC).
METHODS: In total, 312 patients with NSCLC were included, and 580 radiomic features were extracted from the computed tomography images of each patient. In the training set, univariate analysis was performed on the clinical and radiomic features; logistic regression models were established using a 5-fold cross validation strategy for the prediction of EGFR subtypes 19Del and L858R. Subsequently, the predictive ability of the joint models was evaluated using the test set.
RESULTS: The results revealed that the radiomic features specific for EGFR 19Del and L858R were Gabor's MTRVariance, Gabor's PTREntropy, and sphericity. Additionally, the respective areas under the receiver operating characteristic curves of the EGFR 19Del and L858R joint models were 0.7925 and 0.7750 for the test set.
CONCLUSIONS: Our study demonstrated the potential for radiomics to predict EGFR 19Del and L858R. Epidermal growth factor receptor 19Del and L858R exhibited distinct imaging phenotypes, which may help to guide the selection of more accurate and personalized treatment programs for patients with NSCLC.
© 2019 American Association of Physicists in Medicine.

Entities:  

Keywords:  EGFR mutation; ROC curve; computed tomography; logistic models; non-small cell lung cancer; radiomics

Mesh:

Substances:

Year:  2019        PMID: 31376283     DOI: 10.1002/mp.13747

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  22 in total

1.  A Machine Learning-Based Predictive Model of Epidermal Growth Factor Mutations in Lung Adenocarcinomas.

Authors:  Ruimin He; Xiaohua Yang; Tengxiang Li; Yaolin He; Xiaoxue Xie; Qilei Chen; Zijian Zhang; Tingting Cheng
Journal:  Cancers (Basel)       Date:  2022-09-25       Impact factor: 6.575

2.  Diffusion tensor and postcontrast T1-weighted imaging radiomics to differentiate the epidermal growth factor receptor mutation status of brain metastases from non-small cell lung cancer.

Authors:  Yae Won Park; Chansik An; JaeSeong Lee; Kyunghwa Han; Dongmin Choi; Sung Soo Ahn; Hwiyoung Kim; Sung Jun Ahn; Jong Hee Chang; Se Hoon Kim; Seung-Koo Lee
Journal:  Neuroradiology       Date:  2020-08-21       Impact factor: 2.804

3.  Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors.

Authors:  Erica L Carpenter; Despina Kontos; Bardia Yousefi; Michael J LaRiviere; Eric A Cohen; Thomas H Buckingham; Stephanie S Yee; Taylor A Black; Austin L Chien; Peter Noël; Wei-Ting Hwang; Sharyn I Katz; Charu Aggarwal; Jeffrey C Thompson
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

Review 4.  Radiomics as a personalized medicine tool in lung cancer: Separating the hope from the hype.

Authors:  Isabella Fornacon-Wood; Corinne Faivre-Finn; James P B O'Connor; Gareth J Price
Journal:  Lung Cancer       Date:  2020-06-02       Impact factor: 5.705

5.  Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand.

Authors:  Phyu Sin Aye; Sandar Tin Tin; Mark James McKeage; Prashannata Khwaounjoo; Alana Cavadino; J Mark Elwood
Journal:  BMC Cancer       Date:  2020-07-14       Impact factor: 4.430

6.  Contrast-Enhanced CT-Based Radiomics Analysis in Predicting Lymphovascular Invasion in Esophageal Squamous Cell Carcinoma.

Authors:  Yang Li; Meng Yu; Guangda Wang; Li Yang; Chongfei Ma; Mingbo Wang; Meng Yue; Mengdi Cong; Jialiang Ren; Gaofeng Shi
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

7.  Multi-channel multi-task deep learning for predicting EGFR and KRAS mutations of non-small cell lung cancer on CT images.

Authors:  Yunyun Dong; Lina Hou; Wenkai Yang; Jiahao Han; Jiawen Wang; Yan Qiang; Juanjuan Zhao; Jiaxin Hou; Kai Song; Yulan Ma; Ntikurako Guy Fernand Kazihise; Yanfen Cui; Xiaotang Yang
Journal:  Quant Imaging Med Surg       Date:  2021-06

8.  Value of radiomics model based on multi-parametric magnetic resonance imaging in predicting epidermal growth factor receptor mutation status in patients with lung adenocarcinoma.

Authors:  Yuze Wang; Qi Wan; Xiaoying Xia; Jianfeng Hu; Yuting Liao; Peng Wang; Yu Peng; Hongyan Liu; Xinchun Li
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

9.  Radiomics Prediction of EGFR Status in Lung Cancer-Our Experience in Using Multiple Feature Extractors and The Cancer Imaging Archive Data.

Authors:  Lin Lu; Shawn H Sun; Hao Yang; Linning E; Pingzhen Guo; Lawrence H Schwartz; Binsheng Zhao
Journal:  Tomography       Date:  2020-06

10.  3D radiomics predicts EGFR mutation, exon-19 deletion and exon-21 L858R mutation in lung adenocarcinoma.

Authors:  Guixue Liu; Zhihan Xu; Yingqian Ge; Beibei Jiang; Harry Groen; Rozemarijn Vliegenthart; Xueqian Xie
Journal:  Transl Lung Cancer Res       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.